Cas:34114-98-2 t-2 triol manufacturer & supplier

We serve Chemical Name:t-2 triol CAS:34114-98-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

t-2 triol

Chemical Name:t-2 triol
CAS.NO:34114-98-2
Synonyms:Butanoic acid, 3-methyl-, (2α,3α,4β,6β,8β,11β,12ξ)-12,13-epoxy-3,4,15-trihydroxytrichothec-9-en-8-yl ester;t-2 triol;Butanoic acid, 3-methyl-, 12,13-epoxy-3,4,15-trihydroxytrichothec-9-en-8-yl ester;3,4,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate;(3β,4α,8α,12ξ)-3,4,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate
Molecular Formula:C20H30O7
Molecular Weight:382.448
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:527.1±50.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.582
PSA:108.75000
Exact Mass:382.199158
LogP:1.50

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 1
Packing Group:


Contact us for information like Butanoic acid, 3-methyl-, (2α,3α,4β,6β,8β,11β,12ξ)-12,13-epoxy-3,4,15-trihydroxytrichothec-9-en-8-yl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3β,4α,8α,12ξ)-3,4,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate Use and application,Butanoic acid, 3-methyl-, 12,13-epoxy-3,4,15-trihydroxytrichothec-9-en-8-yl ester technical grade,usp/ep/jp grade.


Related News: GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. 2-Pyridinecarboxylic acid, 4-(cyclopropylmethoxy)- manufacturers A number of drugmakers are also developing inhaled treatments for COVID-19, including Verona Pharma. (Z)-2-((2-(tert-butyl)hydrazineylidene)(2-hydroxy-5-(trifluoromethyl)phenyl)methyl)pyridin-3-ol suppliers The continued momentum follows other major milestones and announcements from this year, including a $125 million Series D raise, $1.73 billion valuation, and key leadership team additions such as Prince Harry, The Duke of Sussex, as the company’s Chief Impact Officer. aluminum,iodo hypoiodite vendor & factory.